Lee's Pharmaceutical Licenses Recordati's Zanidip

Hypertension is major problem in China. The cardiovascular disease affects approximately 200mn individuals and places a significant burden on society. Diagnosis rates are low and left untreated, high blood pressure can result in strokes, heart attacks, and cardiac failure. However, with rising wealth and greater investment in the healthcare sector, BMI believes there is a growing opportunity in the Asian country for manufacturers of antihypertensives.

To read the full article, please choose one of the following options: